Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 640268108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
TCG Crossover GP II, LLC
13G/A
Amendment 2
|
0% |
11/14/2025
Event 9/30/2025
|
|
| TCG Crossover GP II, LLC | 0% | ||
| TCG Crossover Fund II, L.P. | 0% | ||
| Chen Yu | 0% | ||
|
TCG Crossover GP II, LLC
13G/A
Amendment 1
|
9.3% |
8/14/2025
Event 6/30/2025
|
|
| TCG Crossover GP II, LLC | 9.3% | ||
| TCG Crossover Fund II, L.P. | 9.3% | ||
| Chen Yu | 9.3% | ||
|
Samlyn Capital, LLC
13G/A
Amendment 1
|
0% |
5/15/2025
Event 3/31/2025
|
|
| Samlyn Capital, LLC | 0% | ||
| Samlyn, LP | 0% | ||
| Robert Pohly | 0% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 6.7% |
4/17/2025
Event 3/31/2025
|
|
|
Eventide Asset Management, LLC
13G/A
Amendment 1
|
3.6% |
2/14/2025
Event 12/31/2024
|
|
| Eventide Asset Management, LLC | 3.6% | ||
| Finny Kuruvilla, M.D., Ph. D. | 3.6% | ||
| Robin C. John | 3.6% | ||
|
Deep Track Capital, LP
13G/A
Amendment 3
|
1.1% |
2/14/2025
Event 12/31/2024
|
|
| Deep Track Capital, LP | 1.1% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 1.1% | ||
| David Kroin | 1.1% | ||
|
Samlyn Capital, LLC
13G
|
5.2% |
2/14/2025
Event 12/31/2024
|
|
| Samlyn Capital, LLC | 5.2% | ||
| Samlyn, LP | 5.2% | ||
| Robert Pohly | 5.2% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 1 | 1.00 | $1.00 |
| 2026 Q1 | 8 | 187 | $13.4 k |
| 2025 Q4 | 8 | 6.80 k | $287 k |
| 2025 Q3 | 9 | 7.27 k | $414 k |
| 2025 Q2 | 9 | 10.2 k | $150 k |
| 2025 Q1 | 166 | 124 M | $84.4 M |
| 2024 Q4 | 153 | 134 M | $124 M |
| 2024 Q3 | 145 | 142 M | $184 M |
| 2024 Q2 | 144 | 141 M | $175 M |
| 2024 Q1 | 130 | 113 M | $106 M |
| 2023 Q4 | 134 | 121 M | $68.1 M |
| 2023 Q3 | 143 | 143 M | $85.3 M |
| 2023 Q2 | 154 | 138 M | $79.3 M |
| 2023 Q1 | 203 | 173 M | $121 M |
| 2022 Q4 | 225 | 177 M | $399 M |
| 2022 Q3 | 245 | 176 M | $564 M |
| 2022 Q2 | 243 | 183 M | $695 M |
| 2022 Q1 | 279 | 176 M | $951 M |
| 2021 Q4 | 280 | 174 M | $2.36 B |
| 2021 Q3 | 262 | 168 M | $3.01 B |
| 2021 Q2 | 261 | 169 M | $2.90 B |
| 2021 Q1 | 255 | 170 M | $3.40 B |
| 2020 Q4 | 285 | 174 M | $2.95 B |
| 2020 Q3 | 275 | 176 M | $2.92 B |
| 2020 Q2 | 290 | 175 M | $4.06 B |
| 2020 Q1 | 275 | 177 M | $3.19 B |
| 2019 Q4 | 311 | 178 M | $3.84 B |
| 2019 Q3 | 324 | 178 M | $3.25 B |
| 2019 Q2 | 377 | 168 M | $5.96 B |
| 2019 Q1 | 384 | 163 M | $5.49 B |
| 2018 Q4 | 383 | 167 M | $5.50 B |
| 2018 Q3 | 431 | 163 M | $9.92 B |
| 2018 Q2 | 418 | 161 M | $7.86 B |
| 2018 Q1 | 393 | 158 M | $16.7 B |
| 2017 Q4 | 298 | 155 M | $9.25 B |
| 2017 Q3 | 227 | 154 M | $3.69 B |
| 2017 Q2 | 219 | 151 M | $2.96 B |
| 2017 Q1 | 228 | 147 M | $3.45 B |
| 2016 Q4 | 221 | 146 M | $1.79 B |
| 2016 Q3 | 210 | 134 M | $2.29 B |
| 2016 Q2 | 194 | 135 M | $1.92 B |
| 2016 Q1 | 191 | 139 M | $1.91 B |
| 2015 Q4 | 200 | 168 M | $2.83 B |
| 2015 Q3 | 181 | 145 M | $1.58 B |
| 2015 Q2 | 199 | 138 M | $1.73 B |
| 2015 Q1 | 168 | 126 M | $1.39 B |
| 2014 Q4 | 174 | 122 M | $1.89 B |
| 2014 Q3 | 157 | 118 M | $1.43 B |
| 2014 Q2 | 161 | 119 M | $1.52 B |
| 2014 Q1 | 150 | 116 M | $1.40 B |